Both in Pharmaceuticals
Innoviva vs Mineralys Therapeutics
Over the past year INVA returned +17.7% and MLYS returned −57.5%; their daily moves had a correlation of 0.09.
INVA +17.7% MLYS −57.5%Growth of $1, one year, split-adjusted
| Metric | INVA | MLYS |
|---|---|---|
| Price | $21.32 | $16.67 |
| Market cap | $1.54B | $1.47B |
| Today | +1.84% | +4.22% |
| 1 month | +2.3% | −24.1% |
| 6 months | −5.4% | −44.7% |
| Year to date | +6.6% | −54.1% |
| 1 year | +17.7% | −57.5% |
| Revenue growth (YoY) | +19.3% | — |
| Gross margin | 81.3% | — |
| Net margin | −69.8% | — |
| P/E (TTM) | 4.3× | — |
| Price / sales | 3.5× | — |
| Net cash | $319.0M | $563.8M |
| Dividend yield | — | — |
| Volatility (60d) | 21.2% | 73.1% |
| Short % of float | 10.5% | 11.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).